Skip to content
Awesome – Lifestyle
Author:
Bicara Therapeutics Inc.
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
March 6, 2026
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 5, 2026
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
March 4, 2026
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
March 4, 2026
←
Previous Page
1
2